Philadelphia-based Thomas Jefferson University, owner of Jefferson Health, recorded an operating loss of $29.3 million (-0.3% operating margin) through the first three quarters of fiscal 2025, compared to an operating loss of $30.2 million (-0.4% margin) during the same period last year, according to its May 15 financial report.
Four things to know:
1. Jefferson’s total operating revenue and expenses through the nine months ended March 31 were each about $4 billion higher than the same period last year, primarily due to its Aug. 1 merger with Allentown, Pa.-based Lehigh Valley Health.
2. Jefferson’s operating revenue through the third quarter of 2025 was $11.3 billion, 5.7% above budget expectations. Net patient service revenue was 3.3% above budget, insurance premium revenue was 6.4% above, and other revenue was 45.4% above, driven mainly by higher ambulatory pharmacy revenue.
3. Operating expenses totaled $11.4 billion through the first three quarters of the fiscal year, 6.2% above budget expectations. The overage was driven by supply costs (12.4% above budget), drugs (24.9% above) and insurance services medical expenses (22.2% above).
4. Jefferson had 117.3 days cash on hand as of March 31, down from 140.4 on June 30.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
